These changes are evident in individuals at high risk for AD, such as those carrying the APOE ε4 allele or those with mild cognitive impairment (MCI), and persist throughout AD progression, correlating with the severity of cognitive decline [146,147]. This evidence concerns the gene APOE and Alzheimer disease.